Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending July 2013. The document serves as a notification of a major interest in shares pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. It details a change in voting rights held by a significant shareholder.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding shareholding changes and does not contain financial performance data.
Material Changes
The material change reported is an acquisition or disposal of voting rights by Legal & General Group Plc (L&G). On July 9, 2013, L&G's total voting rights in GSK Ordinary 25p shares fell below the 3% threshold. The filing notes a previous holding of 207,246,143 shares as of August 17, 2010, but the specific number of shares held after the July 2013 transaction is not explicitly quantified in the text, only that the percentage is now below 3%.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for management guidance, outlook, commentary, risks, contingencies, or unusual items. The document is strictly a notification of shareholding status.
Key Facts for Investor Verification
- Shareholder: Legal & General Group Plc (L&G) and its controlled undertakings.
- Event Date: July 9, 2013 (transaction date); July 10, 2013 (notification date).
- Threshold Change: L&G's total voting rights (Direct + Indirect) dropped below the 3% reporting threshold.
- Share Class: Ordinary 25p shares.
- Total Voting Rights Base: The notification references a total voting rights figure of 4,909,366,589 for GSK.